Patents by Inventor SIMON LAWRENCE

SIMON LAWRENCE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7300762
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein (SEQ ID NO: 2). The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: November 27, 2007
    Assignee: GE Healthcare UK Limited
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Patent number: 7091317
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Grant
    Filed: January 14, 2004
    Date of Patent: August 15, 2006
    Assignee: GE Healthcare Limited
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Patent number: 6950017
    Abstract: A monitor system for monitoring an environment inhabited by an occupant includes a controller having data storage system, a processor, data processing software, at least one input, and at least one output, wherein at least one input includes an output signal from a signal generator associated with a utility meter, the utility meter being arranged to meter a utility entering the monitored environment, wherein the data processing software records and analyzes the or each at least one input, and wherein the at least one output includes an alarm signal generated when the data processing software determines that the utility use pattern is abnormal.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: September 27, 2005
    Inventor: Simon Lawrence Smith
  • Patent number: 6919186
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: July 19, 2005
    Assignee: Amersham plc
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Publication number: 20040138420
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S 175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 15, 2004
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Publication number: 20030189485
    Abstract: A monitor system for monitoring an environment inhabited by an occupant, the system comprises a controller having data storage means, a processor, data processing software, at least one input, and at least one output, wherein one at least one input comprises an output signal from a signal generator associated with a utility meter, the utility meter being arranged to meter a utility entering the monitored environment, wherein the said data processing software records and analyses the or each at least one input, and wherein said at least one output includes an alarm signal generated when the data processing software determines that the utility use pattern is abnormal.
    Type: Application
    Filed: March 25, 2003
    Publication date: October 9, 2003
    Inventor: Simon Lawrence Smith
  • Publication number: 20030175859
    Abstract: The present invention provides novel engineered derivatives of green fluorescent protein (GFP) which have an amino acid sequence which is modified by amino acid substitution compared with the amino acid sequence of wild type Green Fluorescent Protein. The modified GFPs exhibit enhanced fluorescence relative to wtGFP when expressed in non-homologous cells at temperatures above 30° C., and when excited at about 490 nm compared to the parent proteins, i.e. wtGFP. An example of a preferred protein is F64L-S175G-E222G-GFP. The modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wtGFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells.
    Type: Application
    Filed: September 28, 2001
    Publication date: September 18, 2003
    Inventors: Simon Lawrence John Stubbs, Anne Elizabeth Jones, Nigel Paul Michael, Nicholas Thomas
  • Patent number: 6566491
    Abstract: The invention relates to compounds of the formula (I) R1—Q1—X—Q2—R2, in which: Q1, Q2, each independent of one another, are missing or are —NH—(CH2)n—CO—; R1, R2, each independent of one another, are missing or are cyclo-(Arg-Gly-Asp-Z), wherein Z is missing in side chain of Q1 or Q2 of if Q1 and/or Q2 missing, is bound to X, at least one of the groups R1 or R2 always having to be included; X is —CO—R18—CO—, and if R1—Q1— or R2—Q2— are missing is R10, R13, Het-CO or a flourescent pigment residue linked through a —CONH—, —COO—, NH—C(═S)—N—, —NH—C(═O)—NH—, —SO2 NH—or —NHCO— bond; and Z, R10, R13, R16, R18, Het and n have the meaning given in claim 1. The invention also relates to the salts of said compounds.
    Type: Grant
    Filed: August 18, 1998
    Date of Patent: May 20, 2003
    Assignee: Merck Patent Gesellschaft
    Inventors: Alfred Jonczyk, Simon Lawrence Goodman, Beate Diefenbach, Arne Sutter, Horst Kessler
  • Publication number: 20020032306
    Abstract: The invention relates to compounds of the formula (I) R1 Q1 XQ2 R2, in which: Q1, Q2, each independent of one another, are missing or are NH(CH2)n CO; R1, R2, each independent of one another, are missing or are cyclo(ArgGlyAspZ), wherein Z is missing in the side chain of Q1 or Q2 or if Q1 and/or Q2 are missing, is bound to X, at least one of the groups R1 or R2 always having to be included; X is COR 18 CO, and if R1 Q1 or R2 Q2 are missing is R10, R13, R16, HetCO or a fluorescent pigment residue linked through a CONH, COO, NHC (═S)NH, NHC(═O)NH, SO2 NH or NHCO bond; and Z, R10, R13, R16, R18, Het and n have the meanings given in claim 1. The invention also relates to the salts of said compounds. Said compounds and their salts can be used as integrin inhibitors, in particular for the prevention and treatment of circulatory diseases, thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, angiogenic diseases and in tumor therapy.
    Type: Application
    Filed: August 18, 1998
    Publication date: March 14, 2002
    Inventors: ALFRED JONCZYK, SIMON LAWRENCE GOODMAN, BEATE DIEFENBACH, ARNE SUTTER, HORST KESSLER
  • Publication number: 20020025337
    Abstract: The present invention provides a drug delivery composition comprising a lipid vehicle containing a drug and Vitamin E to enhance the solubility of the active drug in the lipid vehicle. The composition is particularly useful for drugs which are poorly soluble. The composition may be in the form of a liposome or an oil-in-water emulsion. The Vitamin E may be mixed with a pharmaceutically acceptable oil such as a marine oil or a vegetable oil.
    Type: Application
    Filed: March 30, 1998
    Publication date: February 28, 2002
    Inventors: LISBETH ILLUM, CLIVE WASHINGTON, SIMON LAWRENCE, PETER WATTS
  • Patent number: 6318457
    Abstract: There is provided a multilateral well and electric transmission system comprising a branch well tubular in a branch wellbore which is connected in an electrically conductive manner to a primary well tubular in a primary wellbore such that the primary and branch well tubulars form a link for transmission of electrical power and/or signals between the primary and branch wellbores. Low voltage electrical power can be transmitted from the surface to a battery in the branch wellbore to trickle-charge the battery and signals from battery-actuated measuring and control equipment in the branch wellbore can be transmitted back to surface via the walls of the electrically interconnected primary and branch well tubulars.
    Type: Grant
    Filed: January 31, 2000
    Date of Patent: November 20, 2001
    Assignee: Shell Oil Company
    Inventors: Johannis Josephus Den Boer, Simon Lawrence Fisher, Anthony Evert Kuperij, John Foreman Stewart
  • Patent number: 6244337
    Abstract: A system for sealing the intersection between a primary borehole and a branch borehole comprises a primary casing section located in the primary borehole in the region of the branchpoint, and a branch casing section located in the branch borehole and secured to the primary casing section. The primary casing section is tubular and defines a slant surface which intersects a central axis of the primary casing section at an acute angle, so that the primary casing section can be pressed towards the branchpoint by means of a hollow whipstock or other wedge-shaped element.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: June 12, 2001
    Assignee: Shell Oil Company
    Inventors: Francis Alexander Cumming, Simon Lawrence Fisher, Wilhelmus Christianus Maria Lohbeck
  • Patent number: 6070671
    Abstract: A method is provided for creating zonal isolation between the exterior and interior of an uncased section of an underground well system which is located adjacent to a well section in which a well casing is present. The method includes inserting an expandable tubular through the existing well casing into an uncased section, such as a lateral branch, of the underground well system and subsequently expanding the expandable tubular such that the one end is pressed towards the wall of the uncased section of the well system and the outer surface of the other end is pressed against the inner surface of the well casing thereby creating an interference fit capable of achieving a shear bond and a hydraulic seal between the surrounding surfaces.
    Type: Grant
    Filed: August 3, 1998
    Date of Patent: June 6, 2000
    Assignee: Shell Oil Company
    Inventors: Francis Alexander Cumming, Simon Lawrence Fisher, Robert Bruce Stewart